← Open Payments lookup

ZAFAR MAHMOOD: Open Payments

NPI 1952361545 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,325 in 74 payments from 10 companies in 2025. Trend: 2023 $808 · 2024 $640 · 2025 $1,325

Food & beverage: $1,214Education: $111
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.22$332
Alkermes, Inc.13$260
Teva Pharmaceuticals USA, Inc.9$188
ABBVIE INC.10$163
Neurocrine BioSciences, Inc.7$145
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$78
Janssen Pharmaceuticals, Inc4$65
Vanda Pharmaceuticals Inc.2$49
E.R. Squibb & Sons, L.L.C.2$31
Lundbeck LLC1$14

Products named: ARISTADA, REXULTI, VRAYLAR, INGREZZA, ABILIFY ASIMTUFII, CAPLYTA, SPRAVATO, FANAPT.

Industry payments across MO — which companies pay providers there.